Juan Gómez Rivas, Associate Professor at Complutense University of Madrid, shared on X:
“Prostate cancer at SIU2026.
From emerging technologies to real-world clinical decisions.
Four topics shaped my participation in this year’s SIU Congress:
- PSMA PET in primary diagnosis: Are we ready for routine clinical implementation?
- Guidelines vs. real-world practice: Addressing the legal and ethical challenges of translating evidence into clinical decisions.
- Treatment de-escalation in mHSPC: Who, when, and how can we safely reduce treatment intensity?
- Genomics and AI: Moving beyond technological innovation towards meaningful clinical applications.

Different topics, but a common question: How do we translate advances in prostate cancer research into better decisions for our patients?
More technology does not automatically mean better care. The challenge is knowing when, how, and for whom to use it.”
You can also read:
